Back to today’s briefing

Story perspectives

U.S. Faces 3-Year Estrogen Patch Shortage Amid Rising Demand

4/11/2026

50 12 Full Breakdown

Summary

Story summary

The U.S. faces a nationwide estrogen patch shortage as demand rises after the FDA lifted a safety warning in November 2025, with usage up 26% by February 2026.
Experts say shortages could last up to three years due to production challenges and rising prescriptions.
Women report difficulty obtaining medications, often turning to multiple pharmacies.
The situation underscores the need for effective menopause management as symptoms may return.

1 of 1

Story summary

The U.S. faces a nationwide estrogen patch shortage as demand rises after the FDA lifted a safety warning in November 2025, with usage up 26% by February 2026.
Experts say shortages could last up to three years due to production challenges and rising prescriptions.
Women report difficulty obtaining medications, often turning to multiple pharmacies.
The situation underscores the need for effective menopause management as symptoms may return.